LY367385 is a potent and selective mGluR1a antagonist with neuroprotective, anticonvulsant, and antiepileptic effects; it attenuates NMDA-induced neuronal degeneration in a concentration-dependent manner; suppresses sound-induced clonic seizures in DBA/2 mice and genetically epilepsy-prone rats (GEPR); and reduces spontaneous spike-and-wave discharges in lethargic mice.